The likelihood that the House Appropriations Committee will fully fund the FDA's fiscal 2016 budget request of $4.9 billion looked bleak Wednesday as a subcommittee expressed concerns about the $150 million increase against the backdrop of continuing deficits.
In opening the first hearing on the FDA budget, Rep. Robert Aderholt (R-Ala.), chairman of the Agriculture, Rural Development and FDA Subcommittee, said he anticipates relatively flat funding for the FDA at best. Given current budget constraints, it will be impossible to grant the large increases being requested by the FDA and other agencies as part of the president's budget proposal, he added.
Aderholt's goals in the FDA budget process are to improve agency management and accountability, target funding to the most important programs and ensure the safety of the nation's food supply and medical products.
Several subcommittee members noted that the FDA's funding request is